Customer Support: 800-526-4902
 

Dr. Adele M.K. Gilpin: Lawyer with Hunton & Williams LLP

Dr. Adele M.K. Gilpin

LinkedIn
Dr. Gilpin is an Associate with Hunton & Williams LLP in the FDA practice group.
Associate
Washington,  DC  U.S.A.
www.hunton.com/bios/bio.aspx?id=17816&tab=0013
Phone202-778-2265

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas
  • ......................... 75%
    Drug and Medical Dev...
  • ......................... 25%
    Food, Drug and Cosme...
 
Contact InfoTelephone: 202-778-2265
Cell Phone: 410-961-7582
Fax: 202-778-7425
http://www.hunton.com/bios/bio.aspx?id=17816&tab=0013
 
University Temple University (B.A., 1975; M.A., 1980; Ph.D., 1984)
 
Law SchoolGeorgetown University Law Center, J.D., cum laude, 1991
 
Admitted1992, Maryland; 1994, District of Columbia; U.S. District Court, District of Maryland; U.S. Court of Appeals, Baltimore County Circuit
 
Memberships Maryland State and American Bar Associations; The District of Columbia Bar.
 
BornPhiladelphia, Pennsylvania
 
Biography

Recipient, E. Randolph Williams Pro Bono award, 2008. Member, Society for Clinical Trials. Associate Professor, Family Medicine and Epidemiology and Preventive Medicine, U. Maryland. Director of Research, U. Maryland Center for Integrative Medicine (2003-2006). Faculty, (1993-2003) and Adjunct Associate Professor (2003-2007), Center for Clinical Trials, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health. Prior Deputy Director, NIH-funded Sleep Heart Health Study Coordinating Center and Director, A+ Asthma Early Intervention Headstart Trial Coordinating Center. Design and implementation of multi-center clinical trials, including the National Eye Institute-funded "Studies of Ocular Complications of AIDS" trials - testing the efficacy of therapies for cytomegalovirus retinitis in people with AIDS (1993-2003). Chairperson, Data and Safety Monitoring Board, NIH-funded placebo controlled "Clinical Trial of Lorenzo's Oil in AMN". Member, Data and Safety Monitoring Board, completed NIH-funded "Restorative Care Study". Member: Institutional Review Board, Maryland Medical Research Institute; Human Rights Committee, Veteran's Affairs Cooperative Studies Program Coordinating Center at Perry Point. Coursemaster, "Design and Conduct of Clinical Trials," Johns Hopkins School of Public Health (1998-2003). NIH grants applications peer reviewer. Biomedical journals peer reviewer for Annals of Epidemiology, Journal of the American Medical Association, Clinical Journal of Pain, and Annals of Internal Medicine. Named in top 10% of peer reviewers by Annals of Internal Medicine (2005).

 
ISLN900898288
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

FDA Issues Three Draft Guidances on Biosimilar Product Development
Heather D. Banuelos,Adele M.K. Gilpin,Gary C. Messplay,Allison Reschovsky,Brian J. Wesoloski, February 16, 2012
On February 9, 2012, the U.S. Food and Drug Administration (“FDA” or “the Agency”) issued the following three draft guidance documents to assist industry in developing biosimilar products:
Profile Visibility
#6,642 in weekly profile views out of 48,539 lawyers in Washington, District of Columbia
#176,267 in weekly profile views out of 1,461,250 total lawyers Overall

Office Information

Dr. Adele M.K. Gilpin
Hunton & Williams LLP
2200 Pennsylvania Avenue, NW
Washington, DC 20037




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now